Medicare Enrolled

Dr. Sugandh Shetty, MD

Urology Physician · Royal Oak, MI
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
31157 WOODWARD AVE, Royal Oak, MI 48073
2483360123
In practice since 2005 (20 years)
NPI: 1871574913 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Shetty from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Shetty? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Shetty

Dr. Sugandh Shetty is an urology physician in Royal Oak, MI, with 20 years of NPI registration. Based on federal Medicare data, Dr. Shetty performed 2,167 Medicare services across 1,470 unique beneficiaries.

Between the years covered by Open Payments, Dr. Shetty received a total of $5,421 from 51 pharmaceutical and/or device companies across 177 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in urology physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Shetty is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice ▲ Top 26% volume in MI $5,421 industry payments

Medicare Practice Summary

Medicare Utilization ↗
2,167
Medicare services
Top 26% in MI for urology physician
1,470
Unique beneficiaries
$59
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~108 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
707 $93 $235
Automated urinalysis
An automated laboratory test performed on a urine sample to analyze its chemical and physical properties. The procedure uses machinery to detect various substances and cells within the urine.
619 $2 $10
Bladder ultrasound after voiding
An ultrasound scan performed after urination to measure the amount of urine remaining in the bladder.
237 $8 $41
Telephone medical discussion, 11-20 minutes
A phone conversation with a physician lasting between 11 and 20 minutes.
82 $65 $160
Cystourethroscopy
A diagnostic exam of the bladder and urethra using an endoscope to visually inspect the urinary tract.
78 $188 $575
Leuprolide acetate (for depot suspension), 7.5 mg 78 $137 $950
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
61 $123 $354
Complete ultrasound of retroperitoneum
An ultrasound examination of the structures located behind the abdominal cavity.
56 $86 $339
Limited ultrasound of pelvis
A focused ultrasound exam of the pelvic area to evaluate specific structures. This procedure provides images of the pelvis to assist in medical assessment.
49 $38 $173
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
38 $143 $314
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
35 $69 $165
Blood draw (venipuncture)
Insertion of a needle into a vein to collect a blood sample.
25 $5 $6
Subcutaneous or intramuscular chemotherapy injection
This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle.
23 $27 $93
Transrectal ultrasound of the pelvis
An ultrasound imaging procedure where a probe is inserted into the rectum to visualize pelvic structures.
22 $107 $386
Bladder instillation of anti-cancer drug
A procedure where an anti-cancer medication is introduced directly into the bladder. This method delivers the treatment locally to the bladder tissue.
20 $71 $246
Bladder irrigation and/or instillation
This procedure involves flushing the bladder with fluid to clear it or introducing medication directly into the bladder.
14 $57 $185
Annual depression screening 12 $18 $20
Telephone medical discussion, 5-10 minutes
A phone conversation with a physician lasting between 5 and 10 minutes to discuss medical matters.
11 $36 $100
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$5,421
Total received (2018-2024)
Avg $774/year across 7 years
Top 31% in MI for urology physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
51
Companies
177
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$2,995 (55.3%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$2,426 (44.7%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$845
2023
$580
2022
$1,964
2021
$587
2020
$334
2019
$378
2018
$734

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Sumitomo Pharma America, Inc.
$267
Astellas Pharma US Inc
$162
Dendreon Pharmaceuticals LLC
$103
Ferring Pharmaceuticals Inc.
$57
Novartis Pharmaceuticals Corporation
$44
PFIZER INC.
$37
UROGEN PHARMA, INC.
$31
ABBVIE INC.
$30
MIMEDX Group, Inc.
$24
PROGENICS PHARMACEUTICALS, INC.
$22
ACCORD HEALTHCARE, INC.
$16
IMMUNITYBIO, INC.
$14
Myriad Genetic Laboratories, Inc.
$14
Photocure Inc
$13
Smith+Nephew, Inc.
$13
Top 3 companies account for 62.9% of 2024 payments
All-time payments by company (2018-2024) ›
Intuitive Surgical, Inc.
$1,500
Astellas Pharma US Inc
$848
Janssen Biotech, Inc.
$316
Sumitomo Pharma America, Inc.
$314
Dendreon Pharmaceuticals LLC
$248
Janssen Pharmaceuticals, Inc
$144
Coloplast Corp
$141
NxThera, Inc.
$137
Blue Earth Diagnostics Limited
$128
Allergan, Inc.
$115
Amgen Inc.
$113
Dornier MedTech America, Inc
$105
Olympus America Inc.
$100
Myovant Sciences Inc.
$91
Janssen Products, LP
$85
Smith+Nephew, Inc.
$71
AbbVie, Inc.
$68
UROGEN PHARMA, INC.
$65
Avadel Specialty Pharmaceuticals, LLC
$61
Ferring Pharmaceuticals Inc.
$57
Novartis Pharmaceuticals Corporation
$44
180 Medical, Inc.
$42
Endo Pharmaceuticals Inc.
$38
AbbVie Inc.
$38
PFIZER INC.
$37
UroGen Pharma, Inc.
$34
Medtronic, Inc.
$33
ACCORD HEALTHCARE, INC.
$32
ABBVIE INC.
$30
Laborie Medical Technologies Corp.
$29
Myriad Genetic Laboratories, Inc.
$27
Analogic Corporation
$27
MIMEDX Group, Inc.
$24
PROGENICS PHARMACEUTICALS, INC.
$22
Merck Sharp & Dohme LLC
$21
Curium US LLC
$19
NeoTract Inc.
$18
AMAG Pharmaceuticals, Inc.
$18
Tolmar, Inc.
$17
Supernus Pharmaceuticals, Inc.
$17
Axonics Modulation Technologies, Inc.
$16
Bayer HealthCare Pharmaceuticals Inc.
$15
Clovis Oncology, Inc.
$15
IMMUNITYBIO, INC.
$14
TOLMAR Pharmaceuticals, Inc.
$14
Bayer Healthcare Pharmaceuticals Inc.
$14
Photocure Inc
$13
AstraZeneca Pharmaceuticals LP
$13
MEDIVATION FIELD SOLUTIONS LLC
$13
Cook Medical LLC
$13
Allergan Inc.
$11
Top 3 companies account for 49.1% of all-time payments
Associated products mentioned in payments ›
ADSTILADRIN · ANKTIVA · Axonics r-SNM System · Axumin · BOTOX · CAMCEVI · CYSVIEW · DA VINCI SP · Dornier MedTech · ELIGARD · ERLEADA · Erleada · GEMTESA · INTERSTIM · INTRAROSA · INVOKANA · JELMYTO · KEYTRUDA · LUPRON DEPOT · LYNPARZA · Lunderquist · Lupron · MYRBETRIQ · Myrbetriq · Noctiva · Nubeqa · ORGOVYX · Olympus Laser Devices · PLUVICTO · PROLARIS · PROVENGE · PYLARIFY · Porges Coloplast · Prolaris · Prolia · Rezum · Rubraca · STRAVIX · STRAVIX PL · TLANDO · UroLift · VESICARE · XIAFLEX · XTANDI · Xtandi · ZYTIGA · iTIND System
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (55%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for an urology physician in Royal Oak?
Compare urology physicians in the Royal Oak area by procedure volume, costs, and industry payment transparency.
Browse urology physicians nearby

Geographic Context

Urology physicians within 10 mi
172
Per 100K population
13.5
County median income
$95,296
Nearest hospital
BEAUMONT HOSPITAL ROYAL OAK
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Shetty is a clinical cardiology specialist, with above-average Medicare volume (top 26% in MI), with low-engagement industry engagement, with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Shetty experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Shetty performed 707 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Shetty receive payments from pharmaceutical companies?
Yes. Dr. Shetty received a total of $5,421 from 51 companies across 177 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Shetty's costs compare to other urology physicians in Royal Oak?
Dr. Shetty's average Medicare payment per service is $59. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Shetty) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →